Article citationsMore>>

Huang, J., Zhang, J., Xie, Z., Li, L., Chen, M., Li, Y., et al. (2025) Integrated Metabolic-Inflammatory Risk Assessment: HbA1c/HDL-c and hsCRP-to-Albumin Ratios Synergistically Predict Major Adverse Cardiovascular Events in Post-PCI STEMI Patients. Lipids in Health and Disease, 24, Article No. 280.
https://doi.org/10.1186/s12944-025-02707-2

has been cited by the following article:

• TITLE: Research Progress on Inflammation-Related Biomarkers for Prognosis after Emergency PCI in STEMI Patients

  AUTHORS: Zhengkui Qin, Xiuge Tang

  KEYWORDS: Acute ST-Segment Elevation Myocardial Infarction (STEMI), Percutaneous Coronary Intervention (PCI), Inflammatory Biomarkers, Disease Prognosis, Major Adverse Cardiovascular Events (MACE)

  JOURNAL NAME: World Journal of Cardiovascular Diseases, Vol.16 No.6, June 22, 2026

  ABSTRACT: Although emergency percutaneous coronary intervention (PCI) can rapidly restore myocardial perfusion in patients with acute ST-segment elevation myocardial infarction (STEMI), these patients still face a relatively high risk of major adverse cardiovascular events (MACE) after the procedure. The inflammatory response plays a central role in myocardial injury, ventricular remodeling, and thrombosis following STEMI. This article reviews the predictive value of inflammation-related biomarkers—including C-reactive protein, fibrinogen, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, systemic inflammatory response index, and red cell distribution width—for prognosis after emergency PCI in STEMI patients, aiming to provide a reference for clinical risk assessment and stratification.